Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperlipoproteinemia Type II | 5 | 2022 | 373 | 1.590 |
Why?
|
| Coronary Artery Disease | 12 | 2023 | 6454 | 1.430 |
Why?
|
| Multifactorial Inheritance | 4 | 2023 | 1190 | 1.200 |
Why?
|
| Arabs | 2 | 2023 | 177 | 1.010 |
Why?
|
| Penetrance | 3 | 2020 | 380 | 0.780 |
Why?
|
| Receptors, LDL | 3 | 2013 | 475 | 0.760 |
Why?
|
| Plaque, Atherosclerotic | 2 | 2023 | 1499 | 0.760 |
Why?
|
| Genome-Wide Association Study | 5 | 2023 | 12220 | 0.720 |
Why?
|
| Acute Coronary Syndrome | 2 | 2022 | 2337 | 0.620 |
Why?
|
| Coronary Stenosis | 1 | 2023 | 834 | 0.600 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2023 | 17400 | 0.550 |
Why?
|
| Troponin I | 1 | 2020 | 619 | 0.550 |
Why?
|
| Heredodegenerative Disorders, Nervous System | 1 | 2014 | 17 | 0.490 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2020 | 1263 | 0.470 |
Why?
|
| Lipoproteins, LDL | 2 | 2013 | 628 | 0.450 |
Why?
|
| Coronary Vasospasm | 2 | 2023 | 88 | 0.440 |
Why?
|
| Therapies, Investigational | 1 | 2014 | 111 | 0.440 |
Why?
|
| Urachus | 1 | 2012 | 18 | 0.430 |
Why?
|
| Homozygote | 3 | 2013 | 1777 | 0.430 |
Why?
|
| Cystadenocarcinoma, Mucinous | 1 | 2012 | 49 | 0.420 |
Why?
|
| Ubiquitins | 1 | 2014 | 383 | 0.420 |
Why?
|
| Cystadenoma, Mucinous | 1 | 2012 | 59 | 0.420 |
Why?
|
| Pedigree | 10 | 2020 | 4646 | 0.410 |
Why?
|
| Genetic Association Studies | 5 | 2015 | 2699 | 0.380 |
Why?
|
| Heart Defects, Congenital | 4 | 2017 | 4566 | 0.370 |
Why?
|
| Genetic Heterogeneity | 1 | 2014 | 732 | 0.370 |
Why?
|
| Myocardial Perfusion Imaging | 2 | 2023 | 555 | 0.310 |
Why?
|
| Mutation | 6 | 2018 | 29717 | 0.290 |
Why?
|
| Carotid Artery Diseases | 1 | 2013 | 882 | 0.290 |
Why?
|
| Lebanon | 5 | 2018 | 227 | 0.290 |
Why?
|
| Carcinoma in Situ | 1 | 2012 | 802 | 0.280 |
Why?
|
| Clinical Trials as Topic | 1 | 2022 | 7901 | 0.280 |
Why?
|
| Phenotype | 7 | 2023 | 16331 | 0.270 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2022 | 90 | 0.220 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 3444 | 0.210 |
Why?
|
| Genes, Dominant | 2 | 2014 | 880 | 0.190 |
Why?
|
| Humans | 36 | 2023 | 742088 | 0.180 |
Why?
|
| Risk Factors | 9 | 2023 | 72145 | 0.180 |
Why?
|
| Founder Effect | 1 | 2020 | 190 | 0.180 |
Why?
|
| Coronary Vessels | 2 | 2023 | 3099 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 11695 | 0.170 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2012 | 2229 | 0.170 |
Why?
|
| Case-Control Studies | 5 | 2022 | 21719 | 0.170 |
Why?
|
| Sebaceous Glands | 1 | 2018 | 41 | 0.170 |
Why?
|
| Odds Ratio | 3 | 2020 | 9846 | 0.170 |
Why?
|
| Heterozygote | 3 | 2020 | 2790 | 0.170 |
Why?
|
| Eccrine Glands | 1 | 2018 | 45 | 0.160 |
Why?
|
| Life Change Events | 1 | 2023 | 937 | 0.160 |
Why?
|
| Pharmacogenetics | 1 | 2022 | 676 | 0.150 |
Why?
|
| Anterior Eye Segment | 1 | 2018 | 153 | 0.150 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2018 | 117 | 0.150 |
Why?
|
| Codon, Nonsense | 2 | 2015 | 281 | 0.140 |
Why?
|
| Hair Follicle | 1 | 2018 | 209 | 0.140 |
Why?
|
| Aortic Coarctation | 1 | 2018 | 281 | 0.140 |
Why?
|
| Costs and Cost Analysis | 1 | 2022 | 1679 | 0.140 |
Why?
|
| Eye Abnormalities | 1 | 2018 | 246 | 0.140 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2020 | 379 | 0.130 |
Why?
|
| Genome | 1 | 2023 | 1803 | 0.130 |
Why?
|
| Atherosclerosis | 2 | 2022 | 3428 | 0.120 |
Why?
|
| Coronary Angiography | 2 | 2023 | 4567 | 0.120 |
Why?
|
| Myocardium | 2 | 2020 | 4775 | 0.120 |
Why?
|
| Middle Aged | 12 | 2023 | 213127 | 0.120 |
Why?
|
| Predictive Value of Tests | 2 | 2023 | 15056 | 0.110 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2013 | 52 | 0.110 |
Why?
|
| Young Adult | 7 | 2021 | 56350 | 0.110 |
Why?
|
| Pyrazoles | 1 | 2023 | 1970 | 0.110 |
Why?
|
| Consanguinity | 1 | 2015 | 456 | 0.110 |
Why?
|
| Muscular Diseases | 2 | 2013 | 557 | 0.110 |
Why?
|
| Blood Component Removal | 1 | 2013 | 125 | 0.110 |
Why?
|
| Genes, X-Linked | 1 | 2013 | 128 | 0.110 |
Why?
|
| Hyperammonemia | 1 | 2013 | 76 | 0.110 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2020 | 1541 | 0.100 |
Why?
|
| Carnitine | 1 | 2013 | 239 | 0.100 |
Why?
|
| Peer Review, Research | 1 | 2015 | 329 | 0.100 |
Why?
|
| Fetal Heart | 1 | 2013 | 276 | 0.100 |
Why?
|
| Nephrotic Syndrome | 1 | 2015 | 389 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 1 | 2018 | 1613 | 0.100 |
Why?
|
| Male | 17 | 2022 | 349538 | 0.100 |
Why?
|
| Qualitative Research | 2 | 2021 | 2680 | 0.100 |
Why?
|
| Protein Folding | 1 | 2014 | 843 | 0.090 |
Why?
|
| Molecular Typing | 1 | 2010 | 106 | 0.090 |
Why?
|
| Adolescent | 6 | 2020 | 85649 | 0.090 |
Why?
|
| Genes, Recessive | 1 | 2013 | 642 | 0.090 |
Why?
|
| Purines | 2 | 2023 | 593 | 0.090 |
Why?
|
| Chromosome Disorders | 1 | 2013 | 515 | 0.090 |
Why?
|
| Heart Failure | 1 | 2014 | 10856 | 0.090 |
Why?
|
| Echocardiography | 2 | 2020 | 5097 | 0.090 |
Why?
|
| Aneuploidy | 1 | 2013 | 530 | 0.090 |
Why?
|
| Genotype | 2 | 2022 | 12946 | 0.090 |
Why?
|
| Systems Biology | 1 | 2013 | 469 | 0.080 |
Why?
|
| Aged | 7 | 2022 | 162944 | 0.080 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2022 | 3067 | 0.080 |
Why?
|
| Adult | 10 | 2021 | 213712 | 0.080 |
Why?
|
| Perception | 1 | 2015 | 1188 | 0.080 |
Why?
|
| Risk | 1 | 2020 | 9679 | 0.080 |
Why?
|
| DNA Mutational Analysis | 2 | 2015 | 4187 | 0.080 |
Why?
|
| Epigenomics | 1 | 2014 | 902 | 0.080 |
Why?
|
| Cohort Studies | 4 | 2022 | 40450 | 0.080 |
Why?
|
| Child | 6 | 2020 | 77478 | 0.080 |
Why?
|
| Apolipoproteins E | 1 | 2013 | 1438 | 0.080 |
Why?
|
| Syndrome | 2 | 2013 | 3248 | 0.080 |
Why?
|
| Genomics | 1 | 2023 | 5692 | 0.080 |
Why?
|
| Models, Cardiovascular | 1 | 2013 | 994 | 0.080 |
Why?
|
| Point Mutation | 1 | 2013 | 1624 | 0.080 |
Why?
|
| DNA | 1 | 2021 | 7289 | 0.070 |
Why?
|
| Genome, Human | 1 | 2020 | 4420 | 0.070 |
Why?
|
| Guideline Adherence | 1 | 2017 | 2266 | 0.070 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2013 | 851 | 0.070 |
Why?
|
| Exons | 1 | 2012 | 2431 | 0.070 |
Why?
|
| Hypertension | 2 | 2023 | 8455 | 0.070 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 2417 | 0.070 |
Why?
|
| Abnormalities, Multiple | 1 | 2013 | 1416 | 0.070 |
Why?
|
| Female | 12 | 2021 | 379592 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 24913 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 2915 | 0.060 |
Why?
|
| Hemodynamics | 1 | 2014 | 4197 | 0.060 |
Why?
|
| Disease Management | 1 | 2014 | 2450 | 0.050 |
Why?
|
| Aortic Valve Stenosis | 1 | 2015 | 1941 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 3239 | 0.050 |
Why?
|
| Models, Genetic | 1 | 2013 | 3493 | 0.050 |
Why?
|
| Apolipoprotein A-I | 1 | 2023 | 280 | 0.050 |
Why?
|
| Students, Medical | 1 | 2015 | 1858 | 0.050 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2022 | 337 | 0.050 |
Why?
|
| Cholesterol, LDL | 1 | 2010 | 2354 | 0.050 |
Why?
|
| Cardiomyopathies | 1 | 2013 | 1912 | 0.050 |
Why?
|
| Alleles | 1 | 2012 | 6931 | 0.050 |
Why?
|
| Genetic Testing | 1 | 2013 | 3439 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2020 | 6754 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 7276 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 15530 | 0.040 |
Why?
|
| Prevalence | 2 | 2015 | 15194 | 0.040 |
Why?
|
| Lipoprotein(a) | 1 | 2023 | 425 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2015 | 3306 | 0.040 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2023 | 1107 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2015 | 7873 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2015 | 40955 | 0.040 |
Why?
|
| Disease Progression | 1 | 2014 | 13256 | 0.040 |
Why?
|
| NFATC Transcription Factors | 1 | 2018 | 380 | 0.040 |
Why?
|
| Age Factors | 1 | 2013 | 18355 | 0.040 |
Why?
|
| Triglycerides | 1 | 2023 | 2450 | 0.030 |
Why?
|
| Achilles Tendon | 1 | 1997 | 152 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2015 | 12164 | 0.030 |
Why?
|
| Infant | 2 | 2013 | 35070 | 0.030 |
Why?
|
| Diabetic Foot | 1 | 1997 | 352 | 0.030 |
Why?
|
| Monocytes | 1 | 2022 | 2593 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 20774 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 15108 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2013 | 25575 | 0.030 |
Why?
|
| Base Sequence | 2 | 2015 | 12797 | 0.030 |
Why?
|
| Self Report | 1 | 2023 | 3548 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2018 | 3127 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2018 | 1265 | 0.030 |
Why?
|
| Thinking | 1 | 2015 | 319 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2015 | 18112 | 0.020 |
Why?
|
| Focus Groups | 1 | 2015 | 1320 | 0.020 |
Why?
|
| Primary Prevention | 1 | 2017 | 1166 | 0.020 |
Why?
|
| Attitude | 1 | 2015 | 772 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2015 | 2422 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2018 | 4200 | 0.020 |
Why?
|
| Career Choice | 1 | 2015 | 743 | 0.020 |
Why?
|
| DNA Primers | 1 | 2013 | 2892 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2013 | 1526 | 0.020 |
Why?
|
| Schools, Medical | 1 | 2015 | 878 | 0.020 |
Why?
|
| Biopsy | 1 | 2018 | 6756 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 12344 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6534 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 6171 | 0.010 |
Why?
|
| Catheter Ablation | 1 | 2016 | 2746 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 4801 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2015 | 6440 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2015 | 6540 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2018 | 77098 | 0.010 |
Why?
|
| Animals | 2 | 2022 | 168561 | 0.010 |
Why?
|
| Pliability | 1 | 1997 | 63 | 0.010 |
Why?
|
| Logistic Models | 1 | 2013 | 13403 | 0.010 |
Why?
|
| Atrial Fibrillation | 1 | 2016 | 5019 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2021 | 53187 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 39004 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2017 | 23320 | 0.010 |
Why?
|
| Mice | 1 | 2022 | 81045 | 0.010 |
Why?
|
| Osteoarthritis | 1 | 1997 | 1034 | 0.010 |
Why?
|
Concepts
(181)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(41)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_